Funding

• Guidelines for application to CancerCare Manitoba Foundation competition
• Infrastructure Grant Form 2019-2020
• Pilot and Individual Operating Grant Form 2019-2020
• Multi-disciplinary Team Operating Grant Form 2019-2020

• 16 grants submitted, 8 funded
• 50% success rate
• Total $ of awarded grants: $458,347
• Total $ of operating grants: $1,095,290
• Average score: 4.13

Grants awarded to:

• Naseer Ahmed “Identification of cancer specific metabolic signatures in body fluids of the patients with early stage lung cancer using proton magnetic resonance spectroscopy (MRS) and mass spectrometry (MS)”
• David Dawe “Treatment, Outcomes, and Costs for Metastatic Non-Small Cell Lung Cancer in Manitoba”
• Davinder Jassal “Flaxseed in the mitigation of anthracycline and trastuzumab mediated cardiotoxicity (FANTAM) study”
• Kirk McManus “Identifying and Characterizing the Pathogenic Origins of Colorectal Cancer.”
• Yvonne Myal “Delineating the immune regulatory role of prolactin inducible protein (PIP) in breast cancer”
• Marshall Pitz/Harminder Singh ”Developing algorithms to accurately and efficiently identify breast and colorectal cancer recurrence”
• Wayne Xu “Retrospective study of the 10-gene yin yang expression ratio signature for early stage lung cancer”
• Ryan Zarychanski “Heparin anticoagulation to improve outcomes in septic shock: The HALO International Phase II Trial”

Scientific Advisory Committee Members:

• Depeng Jiang
• Richard Keijzer
• Soheila Karimi
• Ji Hyun Ko
• Melanie Martin
• Mojgan  Rastegar
• Louise Simard
• Geert  t’Jong
• Shayne Taback
• Mahmoud Torabi
• Jeffrey Wigle